Olmesartan Impurity 58 | CAS 144689-92-9 - Request Quote
Olmesartan Impurity 58
| SZ CAT No: | SZ-O006108 |
| CAS No | 144689-92-9 |
| Mol.F. | C13H22N2O3 |
| Mol.Wt. | 254.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Olmesartan Impurity 58 is chemically Ethyl 2-butyl-4-(2-hydroxypropan-2-yl)-1H-imidazole-5-carboxylate. Olmesartan Impurity 58 is supplied with detailed characterization data compliant with regulatory guideline. Olmesartan Impurity 58 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Olmesartan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 144689-92-9
Purchase 144689-92-9
Order 144689-92-9
Enquire 144689-92-9
price of 144689-92-9
144689-92-9 Supplier
144689-92-9 Manufacturer
144689-92-9 Exporter
buy high quality Olmesartan Impurity 58
Purchase Olmesartan Impurity 58
Olmesartan Impurity 58 suppliers
Olmesartan Impurity 58 manufacturers
Olmesartan Impurity 58 price
Order Olmesartan Impurity 58
Enquire Olmesartan Impurity 58
Olmesartan Impurity 58 cost
Olmesartan Impurity 58 Supplier
Olmesartan Impurity 58 Distributor
Olmesartan Impurity 58 for Method Validation
Olmesartan Reference Standard
Olmesartan Impurity 58 for ANDA Filing
Olmesartan Impurity 58 for Forced Degradation Studies
Olmesartan Impurity 58 Identification Standards
Olmesartan Impurity 58 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.